当前位置:首页 - 行情中心 - 佛慈制药(002644) - 财务分析 - 现金流量表

佛慈制药

(002644)

  

流通市值:43.97亿  总市值:43.97亿
流通股本:5.11亿   总股本:5.11亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金367,707,401.19184,764,784.85746,709,304.6525,936,783.63
  收到的税费返还1,532,831.181,071.756,681,502.734,046,527.5
  收到其他与经营活动有关的现金19,859,800.648,250,575.0464,108,904.0526,932,002.37
  经营活动现金流入小计389,100,033.01193,016,431.64817,499,711.38556,915,313.5
  购买商品、接受劳务支付的现金188,516,614.76107,464,123.67416,141,183.91308,420,492.82
  支付给职工以及为职工支付的现金71,242,731.6936,604,355.7152,309,473.63113,714,624.07
  支付的各项税费63,398,766.9721,524,053.3688,273,774.7365,232,245.16
  支付其他与经营活动有关的现金48,060,995.3419,313,502.36121,790,355.6585,727,502.04
  经营活动现金流出小计371,219,108.76184,906,035.09778,514,787.92573,094,864.09
  经营活动产生的现金流量净额17,880,924.258,110,396.5538,984,923.46-16,179,550.59
二、投资活动产生的现金流量:
  收回投资收到的现金--338,875-
  取得投资收益收到的现金--1,206,520.54-
  处置固定资产、无形资产和其他长期资产收回的现金净额--21,009.3711,504.42
  投资活动现金流入的平衡项目--00
  投资活动现金流入小计--1,566,404.9111,504.42
  购建固定资产、无形资产和其他长期资产支付的现金10,419,445.337,853,890.1813,289,618.738,789,743.38
  投资活动现金流出小计10,419,445.337,853,890.1813,289,618.738,789,743.38
  投资活动产生的现金流量净额-10,419,445.33-7,853,890.18-11,723,213.82-8,778,238.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金--50,00050,000
  其中:子公司吸收少数股东投资收到的现金--50,00050,000
  取得借款收到的现金2,000,0002,000,00012,000,00010,000,000
  筹资活动现金流入小计2,000,0002,000,00012,050,00010,050,000
  偿还债务支付的现金13,924,52013,724,52023,886,666.6723,400,000
  分配股利、利润或偿付利息支付的现金6,299,571.1788,448.6115,955,346.6616,110,365.54
  支付其他与筹资活动有关的现金--1,209,634.63-
  筹资活动现金流出小计20,224,091.1713,812,968.6141,051,647.9639,510,365.54
  筹资活动产生的现金流量净额-18,224,091.17-11,812,968.61-29,001,647.96-29,460,365.54
四、汇率变动对现金及现金等价物的影响--305,365.07-
五、现金及现金等价物净增加额-10,762,612.25-11,556,462.24-1,434,573.25-54,418,155.09
  加:期初现金及现金等价物余额394,882,120.33397,893,224.19396,316,693.58406,040,604.7
  期末现金及现金等价物余额384,119,508.08386,336,761.95394,882,120.33351,622,449.61
补充资料:
  净利润29,946,434.42-61,665,610.77-
  资产减值准备--33,818,656.91-
  固定资产和投资性房地产折旧24,459,932.43-46,406,834.15-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧24,459,932.43-46,406,834.15-
  无形资产摊销1,796,133.91-3,300,064.18-
  长期待摊费用摊销2,190,890.08-4,569,966.91-
  处置固定资产、无形资产和其他长期资产的损失-1,415.92--40,438.07-
  财务费用378,448.66-535,447.09-
  投资损失3,921,948.13-7,233,165.17-
  递延所得税-1,648,119--8,305,219.23-
  其中:递延所得税资产减少-1,519,091.49--8,161,654.52-
    递延所得税负债增加-129,027.51--143,564.71-
  存货的减少-12,841,171.56-30,258,112.73-
  经营性应收项目的减少-57,642,884.05--62,203,727.2-
  经营性应付项目的增加27,063,261.72--79,847,969.18-
  现金的期末余额384,119,508.08-394,882,120.33-
  减:现金的期初余额394,882,120.33-396,316,693.58-
  现金及现金等价物的净增加额-10,762,612.25--1,434,573.25-
公告日期2025-08-272025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑